HURA · Company research
TuHURA Biosciences, Inc. Common Stock (HURA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| A new patent covers a cancer antibody's possible use for autoimmune disease and infections - Stock Titan | A new patent covers a cancer antibody's possible use for autoimmune disease and infections Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Trading (HURA) With Integrated Risk Controls (HURA:CA) - Stock Traders Daily | Trading (HURA) With Integrated Risk Controls (HURA:CA) Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 12, 2026 | neutral | 0 | 0.6 |
| A cancer patent also covers cell-based treatments, not just antibody-linked drugs - Stock Titan | A cancer patent also covers cell-based treatments, not just antibody-linked drugs Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| Another loan comes from a credit line capped at $50 million for TuHURA Biosciences (HURA). - Stock Titan | Another loan comes from a credit line capped at $50 million for TuHURA Biosciences (HURA). Stock Titan | View source ↗ | Stock Titan | Sep 24, 2026 | neutral | 0 | 0.6 |
| TuHURA Biosciences Inc (NASDAQ: HURA) Share Price, HURA Stock News, HURA Share Price & Updates - Kalkine | TuHURA Biosciences Inc (NASDAQ: HURA) Share Price, HURA Stock News, HURA Share Price & Updates Kalkine | View source ↗ | Kalkine | Aug 22, 2026 | neutral | 0 | 0.6 |
| Citizens reiterates TuHURA Biosciences stock rating on pipeline progress - Investing.com | Citizens reiterates TuHURA Biosciences stock rating on pipeline progress Investing.com | View source ↗ | Investing.com | Aug 18, 2026 | neutral | 0 | 0.6 |
| Is TuHURA Biosciences (HURA) One of the Unstoppable Stocks That Could Double Your Money? - Yahoo Finance | Is TuHURA Biosciences (HURA) One of the Unstoppable Stocks That Could Double Your Money? Yahoo Finance | View source ↗ | Yahoo Finance | Apr 20, 2026 | neutral | 0 | 0.6 |
| TuHURA Biosciences, Inc. (NASDAQ:HURA): Is Breakeven Near? - Simply Wall Street | TuHURA Biosciences, Inc. (NASDAQ:HURA): Is Breakeven Near? Simply Wall Street | View source ↗ | Simply Wall Street | Apr 2, 2026 | neutral | 0 | 0.6 |
| TuHURA Biosciences, Inc.'s (NASDAQ:HURA) Shift From Loss To Profit - Yahoo Finance | TuHURA Biosciences, Inc.'s (NASDAQ:HURA) Shift From Loss To Profit Yahoo Finance | View source ↗ | Yahoo Finance | Apr 2, 2026 | neutral | 0 | 0.6 |
| TuHURA Biosciences, Inc. Common Stock (HURA) Stock Price: Oct 8 Close $1.93 - Gotrade | TuHURA Biosciences, Inc. Common Stock (HURA) Stock Price: Oct 8 Close $1.93 Gotrade | View source ↗ | Gotrade | Mar 18, 2026 | neutral | 0 | 0.6 |
| HURA Stock Strongly Rises on Early Morning Surge - www.timothysykes.com | HURA Stock Strongly Rises on Early Morning Surge www.timothysykes.com | View source ↗ | www.timothysykes.com | Feb 11, 2026 | neutral | 0 | 0.6 |
| HURA Stock Sparks 7,000% Surge In Retail Chatter After FDA Orphan Drug Win For Melanoma Therapy - Stocktwits | HURA Stock Sparks 7,000% Surge In Retail Chatter After FDA Orphan Drug Win For Melanoma Therapy Stocktwits | View source ↗ | Stocktwits | Feb 3, 2026 | neutral | 0 | 0.6 |
| Oracle Executive Sells $2.95 Million in Stock Amid Cloud Expansion - TradingView | Oracle Executive Sells $2.95 Million in Stock Amid Cloud Expansion TradingView | View source ↗ | TradingView | Dec 30, 2025 | neutral | 0 | 0.6 |
| TuHURA Biosciences, Inc. Announces $15.6 Million Registered Direct Offering - PR Newswire | TuHURA Biosciences, Inc. Announces $15.6 Million Registered Direct Offering PR Newswire | View source ↗ | PR Newswire | Dec 9, 2025 | neutral | 0 | 0.6 |
| The recent pullback must have dismayed TuHURA Biosciences, Inc. (NASDAQ:HURA) insiders who own 43% of the company - Simply Wall Street | The recent pullback must have dismayed TuHURA Biosciences, Inc. (NASDAQ:HURA) insiders who own 43% of the company Simply Wall Street | View source ↗ | Simply Wall Street | Oct 23, 2025 | neutral | 0 | 0.6 |
| HURA Stock Price and Chart — NASDAQ:HURA - TradingView | HURA Stock Price and Chart — NASDAQ:HURA TradingView | View source ↗ | TradingView | Oct 15, 2025 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.